World's Best Scientists 2026 revealed!
Gordon Sussman

Gordon Sussman

Gordon Sussman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gordon Sussman sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

The last bar groups every scientist with 807 publications or more.

Gordon Sussman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gordon Sussman sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

The last bar groups every scientist with 157 D-Index or more.

Overview

Gordon Sussman is affiliated with the University of Toronto in Canada, where they have contributed extensively to medical research, particularly in the field of allergy and immunology. Their work spans various subfields including rheumatology, pathology and forensic medicine, genetics, immunology, and pharmacology.

Their research focuses on multiple key topics, including:

  • Urticaria and Related Conditions
  • Autoimmune Bullous Skin Diseases
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Drug-Induced Adverse Reactions
  • Dermatology and Skin Diseases
  • Mast cells and histamine
  • Chronic Lymphocytic Leukemia Research

Sussman has published an extensive collection of papers, with frequent venues being the Journal of Allergy and Clinical Immunology, Annals of Allergy Asthma & Immunology, The Journal of Allergy and Clinical Immunology In Practice, Revue française d'allergologie, and Allergy. Key papers in recent years include:

  • "The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria" (2021), published in Allergy
  • "Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial" (2021), published in Nature Medicine
  • "Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria" (2021), published in Allergy Asthma and Immunology Research
  • "Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial" (2023), published in The Lancet
  • "Cannabis-related allergies: An international overview and consensus recommendations" (2022), published in Allergy

In collaboration, Sussman frequently coauthors with researchers such as Marcus Maurer, Michihiro Hide, Ana M. Giménez-Arnau, Jonathan A. Bernstein, and Martin Metz. Their partnerships reflect multidisciplinary approaches in allergy research and clinical immunology.

Their publications demonstrate a consistent focus on clinical challenges related to allergies, autoimmune conditions, and drug reactions, contributing to evolving guidelines and therapeutic options.

Best Publications

  • The EAACI/GA 2 LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

    T. Zuberbier;W. Aberer;R. Asero;C. Bindslev-Jensen

  • The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.

    T Zuberbier;W Aberer;R Asero;A H Abdul Latiff

  • The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.

    Torsten Zuberbier;Amir Hamzah Abdul Latiff;Mohamed Abuzakouk;Susan Aquilina

  • AR101 Oral Immunotherapy for Peanut Allergy

    Brian P Vickery;Andrea Vereda;Thomas B Casale

  • The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU

    M. Maurer;M. Abuzakouk;F. Berard;W. Canonica

  • Latex allergy can induce clinical reactions to specific foods

    D. H. Beezhold;G. L. Sussman;G. M. Liss;G. M. Liss;Nan-Shan Chang

  • Latex allergy: epidemiological study of 1351 hospital workers.

    G M Liss;G L Sussman;K Deal;S Brown

  • Allergy to Latex Rubber

    Gordon L. Sussman;Donald H. Beezhold

  • The spectrum of IgE-mediated responses to latex.

    Gordon L. Sussman;Susan Tarlo;Jerry Dolovich

  • Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion among Children with Peanut Allergy: The PEPITES Randomized Clinical Trial

    David M. Fleischer;Matthew Greenhawt;Gordon Sussman;Philippe Bégin

  • Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor

    Hilary Longhurst;Marco Cicardi;Timothy Craig;Konrad Bork

  • Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial.

    Hugh A. Sampson;Hugh A. Sampson;Wayne G. Shreffler;William H. Yang;Gordon L. Sussman

  • Control of airborne latex by use of powder-free latex gloves

    Susan M. Tarlo;Gordon Sussman;Anne Contala;Mark C. Swanson

  • Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.

    Alain Didier;Margitta Worm;Friedrich Horak;Gordon Sussman

  • Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study

    Nicole Schoepke;Riccardo Asero;André Ellrich;Marta Ferrer

  • Hypersensitivity to natural latex.

    D. Spaner;J. Dolovich;S. Tarlo;G. Sussman

  • Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.

    Hendrik Nolte;David I. Bernstein;Harold S. Nelson;Jörg Kleine-Tebbe

  • Allergens and natural rubber proteins.

    Gordon L. Sussman;Donald H. Beezhold;Viswanath P. Kurup

  • Latex sensitization : Occupational versus general population prevalence rates

    Gary M. Liss;Gary M. Liss;Gordon L. Sussman

  • Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency ☆: A randomized double-blind trial

    Chaim M Roifman;Harry Schroeder;Melvin Berger;Ricardo Sorensen

Frequent Co-Authors

Donald H. Beezhold
Donald H. Beezhold National Institute for Occupational Safety and Health
Jacques Hébert
Jacques Hébert Université Laval
Marcus Maurer
Marcus Maurer Charité - University Medicine Berlin
Ana Giménez-Arnau
Ana Giménez-Arnau Autonomous University of Barcelona
Martin Metz
Martin Metz Charité - University Medicine Berlin
Michihiro Hide
Michihiro Hide Hiroshima University
Carsten Bindslev-Jensen
Carsten Bindslev-Jensen University of Southern Denmark
André C. Knulst
André C. Knulst Utrecht University
Torsten Zuberbier
Torsten Zuberbier Charité - University Medicine Berlin
Peter Schmid-Grendelmeier
Peter Schmid-Grendelmeier University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related healthcare degrees can open doors to rewarding career paths. Many professionals transition into specialized nursing roles to complement their immunology knowledge. For example, exploring top psychiatric mental health nurse practitioner programs online offers valuable training with excellent clinical placement rates, which is crucial for hands-on experience.

Cost is often a decisive factor. Students looking for less expensive options while maintaining quality should consider the cheapest pmhnp programs. These affordable pathways can reduce the financial burden without compromising educational outcomes.

In terms of career advancement, understanding salary trends helps in making informed decisions. The highest paid dnp specialties provide insight into lucrative fields within healthcare, highlighting where your immunology expertise might be most valued.

For nurse practitioners seeking to expand their scope, programs like the fnp to acute care np bridge program offer a structured route to specialize in acute care settings. This transition can synergize well with a background in immunology, especially in managing complex patient cases.

Best Scientists Citing Gordon Sussman

Trending Scientists

Recently Published Articles